National Health Investors (STU:WX6) Pretax Margin %: 34.53% (As of Mar. 2026) — 25% Below Median

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

STU:WX6 National Health Investors Inc STU:WX6
83 GF Score
Price €70.50
GF Value €71.38
Valuation Fairly Valued
! 4 Warning Signs
View Full Analysis

What is National Health Investors Pretax Margin %?

National Health Investors STU:WX6 +0.71% 83 Pretax Margin % is 34.53% as of Mar. 2026, which is 25% below its 10-year median of 46.23. GuruFocus rates STU:WX6 with a GF Score™ of 83/100 and a GF Value™ of €71.38 (Fairly Valued). The stock has 4 warning signs investors should review. Among 922 REITs companies, National Health Investors ranks worse than 60.95% on this metric.

Pre-Tax margin is calculated as Pre-Tax Income divided by its Revenue. National Health Investors's Pre-Tax Income for the three months ended in Mar. 2026 was €34.4 Mil. National Health Investors's Revenue for the three months ended in Mar. 2026 was €99.6 Mil. Therefore, National Health Investors's pretax margin for the quarter that ended in Mar. 2026 was 34.53%.

The historical rank and industry rank for National Health Investors's Pretax Margin % or its related term are showing as below:

STU:WX6' s Pretax Margin % Range Over the Past 10 Years
Min: 23.51   Med: 46.23   Max: 61.77
Current: 36.55


STU:WX6's Pretax Margin % is ranked worse than
60.95% of 922 companies
in the REITs industry
Industry Median: 47.335 vs STU:WX6: 36.55

National Health Investors  (STU:WX6) Pretax Margin % Explanation

The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.

The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.

It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.

The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.


National Health Investors Pretax Margin % Related Terms


National Health Investors Pretax Margin % Historical Data

* Premium members only.

The historical data trend for National Health Investors's Pretax Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

National Health Investors Pretax Margin % Chart

National Health Investors Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Pretax Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 37.50 23.51 42.02 40.77 37.48

National Health Investors Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Pretax Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 37.87 40.47 36.15 35.72 34.53

STU:WX6 vs MPT, SBRA, DHC: Pretax Margin % Comparison

For the REIT - Healthcare Facilities subindustry, National Health Investors's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


National Health Investors Pretax Margin % vs REITs Industry

For the REITs industry and Real Estate sector, National Health Investors's Pretax Margin % distribution charts can be found below:

* The bar in red indicates where National Health Investors's Pretax Margin % falls into.


STU:WX6
83GF Score
National Health Investors Inc STU:WX6
Pretax Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

National Health Investors Pretax Margin % Calculation

Pretax margin - also known as pretax profit margin is the ratio of Pretax Income divided by net sales or Revenue, usually presented in percent.

National Health Investors's Pretax Margin for the fiscal year that ended in Dec. 2025 is calculated as

Pretax Margin=Pre-Tax Income (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=120.232/320.786
=37.48 %

National Health Investors's Pretax Margin for the quarter that ended in Mar. 2026 is calculated as

Pretax Margin=Pre-Tax Income (Q: Mar. 2026 )/Revenue (Q: Mar. 2026 )
=34.385/99.587
=34.53 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Pretax Margin % →
What does a Pretax Margin % of 34.53% mean?
National Health Investors (STU:WX6) has a Pretax Margin % of 34.53% as of Mar. 2026. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on National Health Investors and its competitors. This is 25% below median its historical median of 46.23. Over the past decade, National Health Investors' Pretax Margin % has ranged from 23.51 to 61.77. According to the industry distribution chart, National Health Investors ranks #562 out of 922 companies in the REITs industry, placing it in the top 61%.
Is National Health Investors' Pretax Margin % too high?
National Health Investors' current Pretax Margin % of 34.53% is 25% below median its 10-year median of 46.23. Over the past 10 years, this metric has ranged from a low of 23.51 to a high of 61.77. The REITs industry median Pretax Margin % is 47.34. National Health Investors' value of 34.53% is 27.1% below this industry median. Based on the distribution chart, National Health Investors ranks #562 out of 922 companies in the REITs industry, which is below the industry midpoint. Overall, National Health Investors has a GF Score™ of 83/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does National Health Investors' Pretax Margin % compare to MPT and SBRA?
According to the REITs industry distribution chart, National Health Investors ranks #562 out of 922 companies for Pretax Margin %. This places National Health Investors in the lower half of its industry. The industry median Pretax Margin % is 47.34. National Health Investors' value of 34.53% is 27.1% below this benchmark. Historically, National Health Investors' own Pretax Margin % has ranged from 23.51 to 61.77 over the past decade. While the company's 10-year median is 46.23 vs. the industry median of 47.34, National Health Investors has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Pretax Margin % for a REITs company?
The median Pretax Margin % among REITs companies is 47.34, based on 922 companies in the industry. Companies in the top quartile (top 25%) have a Pretax Margin % significantly above this median, while those in the bottom quartile fall well below. However, Pretax Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. National Health Investors's current Pretax Margin % of 34.53% is 27.1% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Pretax Margin % mean?
A high Pretax Margin % can signal that a stock is expensive relative to its fundamentals. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on National Health Investors and its competitors. For the REITs industry, the median Pretax Margin % is 47.34 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. National Health Investors's current Pretax Margin % is 34.53%, which is 25% below median its own 10-year median of 46.23. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is National Health Investors stock overvalued right now?
Based on GuruFocus' analysis, National Health Investors (STU:WX6) is currently considered Fairly Valued. The stock's GF Value™ is €71.38, compared to a current price of €70.50 — trading 1.2% below its estimated fair value. The current Pretax Margin % is 34.53%, which is 25% below median its 10-year median of 46.23 and 27.1% below the REITs industry median of 47.34. National Health Investors' overall GF Score™ is 83/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Pretax Margin % calculated?
Pretax Margin % is calculated from a company's financial statements. For National Health Investors (STU:WX6), the current Pretax Margin % is 34.53% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is National Health Investors (STU:WX6) Overvalued in 2026?

Based on GuruFocus' analysis, National Health Investors stock appears to be undervalued. The current stock price of €70.50 is trading 1.2% below its estimated GF Value™ of €71.38. GuruFocus considers National Health Investors to be Fairly Valued.

Key valuation signals for STU:WX6:

  • Pretax Margin %: 34.53% (25% below median its 10-year median of 46.23)
  • GF Value™: €71.38 vs. price of €70.50 (1.2% below fair value)
  • GF Score™: 83/100 with 4 warning signs
  • Industry Position: 27.1% below the REITs median (#562 of 922)

No single metric tells the full story. See the STU:WX6 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


National Health Investors Business Description

Industry Real EstateREITs
Other Exchanges NHI:USAWX6:Germany
Address 222 Robert Rose Drive, Murfreesboro, TN, USA, 37129
National Health Investors Inc is a self-managed REIT that owns, leases, operates, and finances the development of senior housing communities and medical facilities. It operates through two segments: Real Estate Investments and Senior Housing Operating Portfolio (SHOP). The Real Estate Investments segment, which generates the majority of revenue, includes real estate leases, mortgages, and other notes receivable related to independent living facilities, assisted living facilities, entrance fee communities, senior living campuses, skilled nursing facilities, and a hospital. The SHOP segment consists of ventures that own and operate independent living facilities. The company's revenues are derived from rental income, interest and other income, and resident fees and services.
83GF Score

Get the complete analysis for STU:WX6

Pretax Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€70.50
Price
€71.38
GF Value